We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

By LabMedica International staff writers
Posted on 22 Jul 2025

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense. More...

These autoantibodies can go undetected for extended periods, making diagnosis difficult and delaying critical treatment. Traditional testing methods can be slow, expensive, and insensitive to trace levels of harmful antibodies, especially in the early stages of illness. Now, researchers have developed a rapid, highly sensitive paper-based test that enables one-step detection of these autoantibodies in under 10 minutes.

The paper-based diagnostic device called the 3D-osPAD (3D origami signal-amplified paper-based analytical device) has been developed by scientists at National Taiwan University (Taipei, Taiwan) and uses a folded 3D paper structure combined with gold nanoparticle signal amplification to enhance detection. All necessary reagents are preloaded within layered compartments, which allows the assay to initiate automatically once a small drop of diluted blood serum is added. The design enables a one-step, streamlined process that does not require expensive laboratory equipment or specialized training, making it accessible for both hospital and remote clinical settings. This technological innovation significantly improves test sensitivity achieving a tenfold increase over conventional detection methods while delivering results in just 10 minutes.

In the study published in Biosensors and Bioelectronics, the 3D-osPAD was clinically validated and demonstrated 100% sensitivity and specificity in accurately identifying patients with adult-onset immunodeficiency caused by anti-IFN-γ autoantibodies. In addition to its clinical accuracy, the portable and user-friendly design of the test supports applications in rapid diagnosis, treatment planning, and recovery monitoring. The researchers plan to further develop similar user-friendly and highly sensitive analytical tools for on-site diagnostics, especially in resource-limited environments.

Related Links:
National Taiwan University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.